Resources

The Role of AI and Automation in Pharmacovigilance: Transforming Drug Safety and Compliance

Written by Kapil Pateriya | Feb 19, 2025 10:35:33 PM

Introduction

Pharmacovigilance is at the heart of patient safety and regulatory compliance. But manual processes, siloed systems, and increasing case volumes make adverse event reporting complex and time-consuming.

The solution? AI-driven automation.

Companies like Cloudbyz are leveraging machine learning, natural language processing, and automated workflows to revolutionize case processing.

 

Why Pharmacovigilance Needs Automation

  • Rising Case Volume – Increasing clinical trials and real-world drug use mean more adverse event cases to manage.
  • Regulatory Pressure – Agencies like FDA, EMA, and MHRA require fast, accurate submissions.
  • Manual Errors and Delays – Traditional methods introduce risk, inefficiency, and compliance gaps.

 

How Cloudbyz Transforms the Pharmacovigilance Workflow

  • Automated Case Intake – Captures adverse events from spontaneous reports, literature, call centers, and clinical trials.
  • Medical Coding with AI – Uses MedDRA, IMDRF, and HRUG for standardized reporting.
  • Regulatory-Ready Submissions – Supports E2B (R2, R3), MedWatch, CIOMS, and Excel exports.
  • Workflow Automation – Real-time notifications ensure serious cases are flagged and reviewed faster.
  • Seamless Integrations – Connects with EDC, investigator portals, and sponsor platforms.

 

The Impact: Faster, Smarter, More Compliant Pharmacovigilance

With automation, teams can reduce case processing time, enhance compliance, and improve patient safety.

 

Watch the full Cloudbyz demo here: